This compound is a pharmaceutical impurity reference standard used in quality control and analytical testing. It is structurally related to active pharmaceutical ingredients and serves as a certified material for identifying and quantifying impurities in drug substances.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 4-(2-(Dipropylamino)ethyl)indoline-2,3-dione?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Alisertib
pharmaceutical raw material
Lycopsamine
pharmaceutical raw material
8-fluoro-6-methoxymoxifloxacin
pharmaceutical raw material
Capmatinib
pharmaceutical raw material
4,6-Difluoro-1H-indole-2,3-dione
pharmaceutical intermediate
6-Bromo-5,7-difluoroindoline-2,3-dione
research compound
7-Fluoroisatin
research compound
6-Fluoroisatin
research compound
4-[2-(dipropylamino)ethyl]-1H-indole-2,3-dione
VBMMNCUKXRDGAZ-UHFFFAOYSA-N
CCCN(CCC)CCC1=C2C(=CC=C1)NC(=O)C2=O
Sourcing 4-(2-(Dipropylamino)ethyl)indoline-2,3-dione?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.